Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering.

Tissue engineering. Part A - 1 Sept 2009

Hou Tianyong, Xu Jianzhong, Wu Xuehui, Xie Zhao, Luo Fei, Zhang Zehua, Zeng Ling

Abstract excerpt

Although bone marrow-derived mesenchymal stromal cells (BMSCs) are a main cell source for tissue-engineered bone (TEB), the clinical use of BMSCs is restricted due to the invasive bone marrow aspiration procedure and the decline in available number of mesenchymal stromal cells (MSCs) and differentiation potential with increasing age. Umbilical cord-derived MSCs (UCMSCs) are likely to be a promising alternative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkaline Phosphatase
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Morphogenetic Protein 2

Share to Mesenchymal Stem Cells

Share to Osteogenesis

Share to Stromal Cells

Share to Tissue Engineering

Share to Umbilical Cord

Source

Identifiers

PMID: 19231937
DOI: 10.1089/ten.tea.2008.0402

Genes

BMP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering.PMID 19231937Read ↗

Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.Semantic proximity Read ↗

Mesenchymal stem cells: amazing remedies for bone and cartilage defectsSemantic proximity Read ↗

Human mesenchymal stem cells isolated from the umbilical cordSemantic proximity Read ↗

Functional Module Analysis Reveals Differential Osteogenic and Stemness Potentials in Human Mesenchymal Stem Cells from Bone Marrow and Wharton's Jelly of Umbilical CordSemantic proximity Read ↗

Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.Semantic proximity Read ↗

Comparative analysis of human Wharton’s jelly mesenchymal stem cells derived from different parts of the same umbilical cordSemantic proximity Read ↗

Human Amniotic Mesenchymal Stem Cells Promote Endogenous Bone RegenerationSemantic proximity Read ↗

Umbilical Cord is a Rich Source of Mesenchymal Stromal Cells for Cell TherapySemantic proximity Read ↗

Phenotype and Differentiation Potential of Stromal Populations Obtained from Various Zones of Human Umbilical Cord: An OverviewSemantic proximity Read ↗

Osteoinduction in umbilical cord- and palate periosteum-derived mesenchymal stem cells.Semantic proximity Read ↗

Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.Semantic proximity Read ↗

Multi-Lineage Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stromal Cells Mediates Changes in the Expression Profile of Stemness MarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.